Charles River Laboratories (CRL) Q1 2024 Earnings
CRL·Reported May 9, 2024·Before market open
Charles River Laboratories reported Q1 2024 revenue of $1.0B, beat analyst consensus of $992.3M by $19.2M. Diluted EPS came in at $2.27, beat the $2.06 consensus by $0.21.
Revenue
$1.0Bbeat by $19.2M
Consensus: $992.3MDiluted EPS
$2.27beat by $0.21
Consensus: $2.06
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Charles River Laboratories's Q1 2024 earnings report.
Charles River Laboratories (CRL) reported Q1 2024 earnings on May 9, 2024 before market open.
Charles River Laboratories reported revenue of $1.0B and diluted EPS of $2.27 for Q1 2024.
Revenue beat the consensus estimate of $992.3M by $19.2M. EPS beat the consensus estimate of $2.06 by $0.21.
You can read the 10-Q periodic report (0001100682-24-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.